logo

Dermira Inc. (DERM)



Trade DERM now with
  Date
  Headline
10/3/2016 2:17:05 AM Dermira: CIMZIA Phase 3 Trial Meets Co-primary Endpoints In Patients With Moderate-to-Severe Chronic Plaque Psoriasis
10/1/2016 3:49:25 PM Dermira DRM04 Shows Positive In Phase 3 Trial In Primary Axillary Hyperhidrosis
9/12/2016 7:33:08 AM Dermira Buys Option To License Exclusive Rights For Up To Three Early-Stage Programs From Takeda
6/8/2016 7:07:35 AM Dermira Says Prices Underwritten Public Offering Of 4.5 Mln Shares At $28/shr
6/7/2016 4:08:27 PM Dermira Announces Proposed Public Offering Of Common Stock
6/1/2016 4:20:26 PM Dermira Trading Halted; Expected To Resume At 4:35 PM ET
5/10/2016 6:33:29 AM Dermira Q1 Net Loss Widens To $28.4 Mln From $14.0 Mln Last Year
5/10/2016 6:09:04 AM Dermira Unveils Positive Topline Phase 2b Trial Results For DRM01 In Patients With Facial Acne Vulgaris
3/3/2016 7:32:11 AM Dermira Q4 Net Loss $31.2 Mln Vs. Net Loss $6.7 Mln Prior Year
2/29/2016 7:45:34 AM Dermira Completes Patient Enrollment In Phase 3 Clinical Trials For DRM04 In Primary Axillary Hyperhidrosis
1/8/2016 1:01:59 AM Dermira Completes Patient Enrollment For Third CIMZIA Phase 3 Clinical Trial In Psoriasis Program
11/19/2015 7:15:08 AM Dermira Completes Patient Enrollment For Second CIMZIA Phase 3 Clinical Trial In Psoriasis Program
11/10/2015 4:34:54 PM Dermira Q3 Loss/share Of $0.58 Vs. Loss $8.66 Year Ago